HCV and hepatocellular carcinoma: A case-control study in an area of hyperendemicity.

M. Montella, A. Crispo, F. Izzo, D. Ronga, M. Tamburini, M. De Marco, V. Tridente, S. Desicato, G. Fabbrocini, O. Cuomo

Research output: Contribution to journalArticlepeer-review

Abstract

HCV is an RNA virus that cannot be integrated with the host genome; it can, however, exert its oncogenetic potential indirectly by contributing to the modulator effects of the host immune system probably through a capacity to escape the immune system. We have carried out a case controlled study in a hyperendemic area on HCV infection and liver cancer. We screened 114 liver cancer and 226 controls. All patients were at first diagnosis and examined. For liver cancer the risk was (OR=32.9, 95% CI 16.5-65.4, p

Original languageEnglish
Pages (from-to)571-574
Number of pages4
JournalInternational Journal of Molecular Medicine
Volume6
Issue number5
Publication statusPublished - Nov 2000

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'HCV and hepatocellular carcinoma: A case-control study in an area of hyperendemicity.'. Together they form a unique fingerprint.

Cite this